Publicaciones científicas
Generalized pustulosis following Covid 19 vaccination in a patient in treatment with adalimumab
24-dic-2023
| Revista: Journal of the German Society of Dermatology
Inés Oteiza Rius 1 , Ángela Estenaga 2 , Javier Antoñanzas 1 , Ana Morelló Vicente 1 , María Laiño 2 , Josune Mitxelena 2 , Leyre Aguado Gil 1
Dear Editors,
Adalimumab is a tumor necrosis factor (TNF)-α inhibitor commonly used for multiple autoimmune diseases. Paradoxical cutaneous reactions under anti-TNF-α drugs have been described in the literature, predominantly linked to adalimumab.1 Although this adverse effect is widely known, mechanisms underlying its induction, as well as possible risk factors, are still unknown....
CITA DEL ARTÍCULO J Dtsch Dermatol Ges. 2023 Dec 24. doi: 10.1111/ddg.15278
Nuestros autores
